Press Releases

Date	Title	PDF Version
Jun 15, 2011	Alexion to Present at the Wells Fargo Securities Healthcare Conference
Jun 11, 2011	Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
Jun 11, 2011	New Data Show Renal Impairment Is Strong Predictor of Early Death in Patients with PNH
Jun 07, 2011	Alexion to Present at the 31st Annual William Blair & Company Growth Stock Conference
Jun 01, 2011	FDA Grants Priority Review for Alexion's sBLA for Soliris® (eculizumab) as a Treatment for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
May 31, 2011	Alexion to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
May 23, 2011	Researchers to Present Nine Studies on Soliris® (eculizumab) in Patients with PNH and aHUS at EHA Congress
May 12, 2011	Alexion Shareholders Approve Increase in Authorized Shares for Previously Announced Stock Split
May 05, 2011	Alexion to Present at Bank of America Merrill Lynch 2011 Health Care Conference
Apr 26, 2011	Alexion to Present at Deutsche Bank Securities 36th Annual Health Care Conference

Search